Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019

Femke Overbosch; Mark de Boer; Karin Ellen Veldkamp; Pauline Ellerbroek; Chantal P. Bleeker-Rovers; Bram Goorhuis; Michele van Vugt; Annemiek Van Der Eijk; Tjalling Leenstra; Martin Khargi; Jeanette Ros; Diederik Brandwagt; Manon Haverkate; Corien Swaan; Chantal Reusken; Aura Timen; Marion Koopmans; Jaap van Dissel

doi:10.2807/1560-7917.ES.2020.25.15.2000265

Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019

Femke Overbosch
, Mark de Boer
, Karin Ellen Veldkamp
, Pauline Ellerbroek
, Chantal P. Bleeker-Rovers
, Bram Goorhuis
, Michele van Vugt
, Annemiek Van Der Eijk
, Tjalling Leenstra
, Martin Khargi
, Jeanette Ros
, Diederik Brandwagt
, Manon Haverkate
, Corien Swaan
, Chantal Reusken
, Aura Timen^*
, Marion Koopmans
, Jaap van Dissel

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

4 Downloads (Pure)

Abstract

On 20 November 2019, Lassa fever was diagnosed in a physician repatriated from Sierra Leone to the Netherlands. A second physician with suspected Lassa fever, repatriated a few days later from the same healthcare facility, was confirmed infected with Lassa virus on 21 November. Comprehensive contact monitoring involving high- and low-risk contacts proved to be feasible and follow-up of the contacts did not reveal any case of secondary transmission in the Netherlands.

Original language	English
Pages (from-to)	6-10
Number of pages	5
Journal	Eurosurveillance
Volume	25
Issue number	15
DOIs	https://doi.org/10.2807/1560-7917.ES.2020.25.15.2000265
Publication status	Published - 16 Apr 2020

Keywords

Antiviral Agents/therapeutic use
Contact Tracing
Cross Infection
Female
Health Personnel
Humans
Infectious Disease Transmission, Patient-to-Professional
Lassa Fever/diagnosis
Lassa virus/genetics
Male
Netherlands
Reverse Transcriptase Polymerase Chain Reaction
Sierra Leone
Travel
Whole Genome Sequencing

Access to Document

10.2807/1560-7917.ES.2020.25.15.2000265

eurosurv-25-15-2Final published version, 1.43 MB

Cite this

Overbosch, F., de Boer, M., Veldkamp, K. E., Ellerbroek, P., Bleeker-Rovers, C. P., Goorhuis, B., van Vugt, M., Van Der Eijk, A., Leenstra, T., Khargi, M., Ros, J., Brandwagt, D., Haverkate, M., Swaan, C., Reusken, C., Timen, A., Koopmans, M., & van Dissel, J. (2020). Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019. Eurosurveillance, 25(15), 6-10. https://doi.org/10.2807/1560-7917.ES.2020.25.15.2000265

@article{706be4cfa76c4184b2a4be55197f6c33,

title = "Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019",

abstract = "On 20 November 2019, Lassa fever was diagnosed in a physician repatriated from Sierra Leone to the Netherlands. A second physician with suspected Lassa fever, repatriated a few days later from the same healthcare facility, was confirmed infected with Lassa virus on 21 November. Comprehensive contact monitoring involving high- and low-risk contacts proved to be feasible and follow-up of the contacts did not reveal any case of secondary transmission in the Netherlands.",

keywords = "Antiviral Agents/therapeutic use, Contact Tracing, Cross Infection, Female, Health Personnel, Humans, Infectious Disease Transmission, Patient-to-Professional, Lassa Fever/diagnosis, Lassa virus/genetics, Male, Netherlands, Reverse Transcriptase Polymerase Chain Reaction, Sierra Leone, Travel, Whole Genome Sequencing",

author = "Femke Overbosch and \{de Boer\}, Mark and Veldkamp, \{Karin Ellen\} and Pauline Ellerbroek and Bleeker-Rovers, \{Chantal P.\} and Bram Goorhuis and \{van Vugt\}, Michele and \{Van Der Eijk\}, Annemiek and Tjalling Leenstra and Martin Khargi and Jeanette Ros and Diederik Brandwagt and Manon Haverkate and Corien Swaan and Chantal Reusken and Aura Timen and Marion Koopmans and \{van Dissel\}, Jaap",

year = "2020",

month = apr,

day = "16",

doi = "10.2807/1560-7917.ES.2020.25.15.2000265",

language = "English",

volume = "25",

pages = "6--10",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "Centre Europeen pour la Surveillance Epidemiologique du SIDA",

number = "15",

}

Overbosch, F, de Boer, M, Veldkamp, KE, Ellerbroek, P, Bleeker-Rovers, CP, Goorhuis, B, van Vugt, M, Van Der Eijk, A, Leenstra, T, Khargi, M, Ros, J, Brandwagt, D, Haverkate, M, Swaan, C, Reusken, C, Timen, A, Koopmans, M & van Dissel, J 2020, 'Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019', Eurosurveillance, vol. 25, no. 15, pp. 6-10. https://doi.org/10.2807/1560-7917.ES.2020.25.15.2000265

TY - JOUR

T1 - Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019

AU - Overbosch, Femke

AU - de Boer, Mark

AU - Veldkamp, Karin Ellen

AU - Ellerbroek, Pauline

AU - Bleeker-Rovers, Chantal P.

AU - Goorhuis, Bram

AU - van Vugt, Michele

AU - Van Der Eijk, Annemiek

AU - Leenstra, Tjalling

AU - Khargi, Martin

AU - Ros, Jeanette

AU - Brandwagt, Diederik

AU - Haverkate, Manon

AU - Swaan, Corien

AU - Reusken, Chantal

AU - Timen, Aura

AU - Koopmans, Marion

AU - van Dissel, Jaap

PY - 2020/4/16

Y1 - 2020/4/16

N2 - On 20 November 2019, Lassa fever was diagnosed in a physician repatriated from Sierra Leone to the Netherlands. A second physician with suspected Lassa fever, repatriated a few days later from the same healthcare facility, was confirmed infected with Lassa virus on 21 November. Comprehensive contact monitoring involving high- and low-risk contacts proved to be feasible and follow-up of the contacts did not reveal any case of secondary transmission in the Netherlands.

AB - On 20 November 2019, Lassa fever was diagnosed in a physician repatriated from Sierra Leone to the Netherlands. A second physician with suspected Lassa fever, repatriated a few days later from the same healthcare facility, was confirmed infected with Lassa virus on 21 November. Comprehensive contact monitoring involving high- and low-risk contacts proved to be feasible and follow-up of the contacts did not reveal any case of secondary transmission in the Netherlands.

KW - Antiviral Agents/therapeutic use

KW - Contact Tracing

KW - Cross Infection

KW - Female

KW - Health Personnel

KW - Humans

KW - Infectious Disease Transmission, Patient-to-Professional

KW - Lassa Fever/diagnosis

KW - Lassa virus/genetics

KW - Male

KW - Netherlands

KW - Reverse Transcriptase Polymerase Chain Reaction

KW - Sierra Leone

KW - Travel

KW - Whole Genome Sequencing

UR - https://www.scopus.com/pages/publications/85083872302

U2 - 10.2807/1560-7917.ES.2020.25.15.2000265

DO - 10.2807/1560-7917.ES.2020.25.15.2000265

M3 - Review article

C2 - 32317052

AN - SCOPUS:85083872302

SN - 1025-496X

VL - 25

SP - 6

EP - 10

JO - Eurosurveillance

JF - Eurosurveillance

IS - 15

ER -

Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this